Micro-X Limited (ASX:MX1)
0.0250
-0.0010 (-3.85%)
Aug 28, 2026, 4:10 PM AEST
Micro-X Market Cap
Micro-X has a market cap or net worth of 18.7 million as of August 28, 2026. Its market cap has decreased by -64.52% in one year.
Market Cap
18.70M
Enterprise Value
22.04M
Revenue
24.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since December 22, 2015, Micro-X's market cap has decreased from 71.65M to 18.70M, a decrease of -73.90%. That is a compound annual growth rate of -11.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 18.70M | -75.40% |
| Dec 31, 2025 | 76.00M | 55.15% |
| Dec 31, 2024 | 48.98M | -9.95% |
| Dec 29, 2023 | 54.40M | -18.58% |
| Dec 30, 2022 | 66.81M | -43.06% |
| Dec 31, 2021 | 117.33M | -8.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 49.36M |
| HeraMED | 43.98M |
| Nova Eye Medical | 40.59M |
| OncoSil Medical | 35.52M |
| CleanSpace Holdings | 31.56M |
| Control Bionics | 27.16M |
| Memphasys | 18.52M |
| ImpediMed | 18.31M |